Table 1– Demographic and baseline characteristics of chronic obstructive pulmonary disease (COPD) cohort
Subjects9219
Age years69.5±11.1
Male4693 (50.9)
Current smokers3399 (37.1)
Body mass index kg·m−227.2±6.3
FEV1 % predicted60.6±19.9
Severity of airflow limitation by FEV1 % predicted classification7480
 Mild (≥80%)1307 (17.5)
 Moderate (≥50% and <80%)3891 (52.0)
 Severe (≥30% and <50%)1891 (25.3)
 Very severe (<30%)391 (5.2)
Number of COPD exacerbations in the past 12 months9219
 05140 (55.8)
 12017 (21.9)
 ≥22062 (22.4)
Mean rate of exacerbations in the past 12 months per patient per year0.89
mMRC dyspnoea score#7119
 01184 (16.6)
 12633 (37.0)
 21952 (27.4)
 31066 (15.0)
 4284 (4.0)
Comorbidities
 Any comorbidity7267 (78.8)
 Cardiovascular disease4225 (46.1)
 Asthma2141 (23.4)
 Cerebrovascular disease1504 (16.6)
 Depression1348 (15.2)
 Cancer1314 (14.7)
 Lung cancer308 (3.5)
 Diabetes1244 (13.6)
 Osteoporosis978 (11.0)
COPD medication
 Any COPD medication8053 (87.4)
 Short-acting β-agonists6896 (74.8)
 Short-acting anticholinergics834 (9.0)
 Tiotropium4273 (46.3)
 ICS1228 (13.3)
 LABA476 (5.2)
 ICS plus LABA combination5146 (55.8)
  • Data are presented as n, mean±sd or n (%). Percentages are calculated from the number of valid answers to each individual characteristic and, due to missing values, may not necessarily be based on the entire cohort of 9219. FEV1: forced expiratory volume in 1 s; mMRC: modified Medical Research Council; ICS: inhaled corticosteroids; LABA: long-acting β-agonists. #: MRC grades 1–5 were captured, these are equivalent (and have identical wording) to mMRC 0–4, as follows. 0: only breathless with strenuous exercise; 1: breathless when hurrying on the level or up a slight hill; 2: walk slower than people of same age on the level due to breathlessness or stop for breath when walking on level at own pace; 3: stop for breath after walking 100 yards or a few minutes on the level; and 4: too breathless to leave house or breathless when dressing.